Icosavax Performance
| ICVXDelisted Stock | USD 9.02 0.12 1.31% |
The company retains a Market Volatility (i.e., Beta) of 0.9, which attests to possible diversification benefits within a given portfolio. Icosavax returns are very sensitive to returns on the market. As the market goes up or down, Icosavax is expected to follow. Icosavax right now retains a risk of 0.0%. Please check out Icosavax value at risk, as well as the relationship between the kurtosis and market facilitation index , to decide if Icosavax will be following its current trending patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Icosavax has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Icosavax is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 65.6 M |
Icosavax |
Icosavax Relative Risk vs. Return Landscape
If you would invest 902.00 in Icosavax on November 2, 2024 and sell it today you would earn a total of 0.00 from holding Icosavax or generate 0.0% return on investment over 90 days. Icosavax is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Icosavax, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Icosavax Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Icosavax's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Icosavax, and traders can use it to determine the average amount a Icosavax's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ICVX |
Based on monthly moving average Icosavax is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Icosavax by adding Icosavax to a well-diversified portfolio.
Icosavax Fundamentals Growth
Icosavax Stock prices reflect investors' perceptions of the future prospects and financial health of Icosavax, and Icosavax fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Icosavax Stock performance.
| Return On Equity | -0.42 | |||
| Return On Asset | -0.27 | |||
| Current Valuation | 547.9 M | |||
| Shares Outstanding | 50.23 M | |||
| Price To Earning | 63.56 X | |||
| Price To Book | 3.31 X | |||
| Price To Sales | 153.31 X | |||
| EBITDA | (103.19 M) | |||
| Cash And Equivalents | 242.8 M | |||
| Cash Per Share | 6.09 X | |||
| Total Debt | 8.79 M | |||
| Debt To Equity | 0.03 % | |||
| Book Value Per Share | 4.64 X | |||
| Cash Flow From Operations | (71.48 M) | |||
| Earnings Per Share | (2.20) X | |||
| Total Asset | 238.68 M | |||
| Retained Earnings | (185.83 M) | |||
About Icosavax Performance
Evaluating Icosavax's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Icosavax has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Icosavax has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company was incorporated in 2017 and is headquartered in Seattle, Washington. Icosavax operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people.Things to note about Icosavax performance evaluation
Checking the ongoing alerts about Icosavax for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Icosavax help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Icosavax is not yet fully synchronised with the market data | |
| Icosavax has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (96.71 M) with loss before overhead, payroll, taxes, and interest of (30.97 M). | |
| Icosavax currently holds about 242.8 M in cash with (71.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.09. | |
| Over 88.0% of the company shares are owned by institutional investors |
- Analyzing Icosavax's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Icosavax's stock is overvalued or undervalued compared to its peers.
- Examining Icosavax's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Icosavax's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Icosavax's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Icosavax's stock. These opinions can provide insight into Icosavax's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Icosavax Stock
If you are still planning to invest in Icosavax check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Icosavax's history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |